Engineering and combining oncolytic measles virus for cancer therapy
Cancer immunotherapy using tumor-selective, oncolytic viruses is an emerging therapeutic option for solid and hematologic malignancies. A considerable variety of viruses ranging from small picornaviruses to large poxviruses are currently being investigated as potential candidates. In the early days...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
3 July 2020
|
| In: |
Cytokine & growth factor reviews
Year: 2020, Jahrgang: 56, Pages: 39-48 |
| ISSN: | 1879-0305 |
| DOI: | 10.1016/j.cytogfr.2020.07.005 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.cytogfr.2020.07.005 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1359610120301490 
|
| Verfasserangaben: | Mathias F. Leber, Serge Neault, Elise Jirovec, Russell Barkley, Aida Said, John C. Bell, Guy Ungerechts |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1748392964 | ||
| 003 | DE-627 | ||
| 005 | 20220819110014.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210216s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cytogfr.2020.07.005 |2 doi | |
| 035 | |a (DE-627)1748392964 | ||
| 035 | |a (DE-599)KXP1748392964 | ||
| 035 | |a (OCoLC)1341393380 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Leber, Mathias Felix |d 1985- |e VerfasserIn |0 (DE-588)1057902306 |0 (DE-627)795388780 |0 (DE-576)413908348 |4 aut | |
| 245 | 1 | 0 | |a Engineering and combining oncolytic measles virus for cancer therapy |c Mathias F. Leber, Serge Neault, Elise Jirovec, Russell Barkley, Aida Said, John C. Bell, Guy Ungerechts |
| 264 | 1 | |c 3 July 2020 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 16.02.2021 | ||
| 520 | |a Cancer immunotherapy using tumor-selective, oncolytic viruses is an emerging therapeutic option for solid and hematologic malignancies. A considerable variety of viruses ranging from small picornaviruses to large poxviruses are currently being investigated as potential candidates. In the early days of virotherapy, non-engineered wild-type or vaccine-strain viruses were employed. However, these viruses often did not fully satisfy the major criteria of safety and efficacy. Since the advent of reverse genetics systems for manipulating various classes of viruses, the field has shifted to developing genetically engineered viruses with an improved therapeutic index. In this review, we will summarize the concepts and strategies of multi-level genetic engineering of oncolytic measles virus, a prime candidate for cancer immunovirotherapy. Furthermore, we will provide a brief overview of measles virus-based multimodal combination therapies for improved tumor control and clinical efficacy. | ||
| 650 | 4 | |a Combination therapy | |
| 650 | 4 | |a Genetic engineering | |
| 650 | 4 | |a Immunotherapy | |
| 650 | 4 | |a Measles virus | |
| 650 | 4 | |a Oncolytic virus | |
| 650 | 4 | |a Virotherapy | |
| 700 | 1 | |a Neault, Serge |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jirovec, Elise |e VerfasserIn |4 aut | |
| 700 | 1 | |a Barkley, Russell |e VerfasserIn |4 aut | |
| 700 | 1 | |a Said, Aida |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bell, John C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ungerechts, Guy |d 1972- |e VerfasserIn |0 (DE-588)124557902 |0 (DE-627)363420053 |0 (DE-576)294230939 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cytokine & growth factor reviews |d Amsterdam [u.a.] : Elsevier Science, 1996 |g 56(2020), Seite 39-48 |h Online-Ressource |w (DE-627)320651045 |w (DE-600)2025966-9 |w (DE-576)103939245 |x 1879-0305 |7 nnas |a Engineering and combining oncolytic measles virus for cancer therapy |
| 773 | 1 | 8 | |g volume:56 |g year:2020 |g pages:39-48 |g extent:10 |a Engineering and combining oncolytic measles virus for cancer therapy |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.cytogfr.2020.07.005 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S1359610120301490 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210216 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 124557902 |a Ungerechts, Guy |m 124557902:Ungerechts, Guy |d 910000 |d 910100 |e 910000PU124557902 |e 910100PU124557902 |k 0/910000/ |k 1/910000/910100/ |p 7 |y j | ||
| 998 | |g 1057902306 |a Leber, Mathias Felix |m 1057902306:Leber, Mathias Felix |d 910000 |d 910100 |e 910000PL1057902306 |e 910100PL1057902306 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1748392964 |e 3855392536 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"10 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"[1996]-","publisher":"Elsevier Science","publisherPlace":"Amsterdam [u.a.]"}],"id":{"issn":["1879-0305"],"zdb":["2025966-9"],"eki":["320651045"]},"pubHistory":["Vol. 7, no. 1 (1996)-"],"titleAlt":[{"title":"Cytokine and growth factor reviews"}],"part":{"year":"2020","pages":"39-48","text":"56(2020), Seite 39-48","volume":"56","extent":"10"},"note":["Gesehen am 03.04.2023","Ungezählte Beil.: Supplement"],"disp":"Engineering and combining oncolytic measles virus for cancer therapyCytokine & growth factor reviews","type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"recId":"320651045","title":[{"title":"Cytokine & growth factor reviews","title_sort":"Cytokine & growth factor reviews"}]}],"name":{"displayForm":["Mathias F. Leber, Serge Neault, Elise Jirovec, Russell Barkley, Aida Said, John C. Bell, Guy Ungerechts"]},"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"3 July 2020"}],"id":{"eki":["1748392964"],"doi":["10.1016/j.cytogfr.2020.07.005"]},"note":["Gesehen am 16.02.2021"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1748392964","language":["eng"],"person":[{"display":"Leber, Mathias Felix","roleDisplay":"VerfasserIn","role":"aut","family":"Leber","given":"Mathias Felix"},{"display":"Neault, Serge","roleDisplay":"VerfasserIn","role":"aut","family":"Neault","given":"Serge"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Jirovec, Elise","given":"Elise","family":"Jirovec"},{"given":"Russell","family":"Barkley","role":"aut","roleDisplay":"VerfasserIn","display":"Barkley, Russell"},{"family":"Said","given":"Aida","roleDisplay":"VerfasserIn","display":"Said, Aida","role":"aut"},{"family":"Bell","given":"John C.","roleDisplay":"VerfasserIn","display":"Bell, John C.","role":"aut"},{"family":"Ungerechts","given":"Guy","roleDisplay":"VerfasserIn","display":"Ungerechts, Guy","role":"aut"}],"title":[{"title_sort":"Engineering and combining oncolytic measles virus for cancer therapy","title":"Engineering and combining oncolytic measles virus for cancer therapy"}]} | ||
| SRT | |a LEBERMATHIENGINEERIN3202 | ||